The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Living near major traffic linked to higher risk of dementiaPeople who live close to high-traffic roadways face a higher risk of developing dementia than those who live further away, new research has found. …...
Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study
Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity studyMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Results Announced from Phase 2 Myelin Repair Trial in Relapsing MS/About-the-Society/News/Results-Announced-from-Phase-2-Myelin-Repair-Tria … read morePosted At: National MS Society
New Guidelines for the Use of Plasma Exchange Therapy in MS/About-the-Society/News/New-Guidelines-for-the-Use-of-Plasma-Exchange-Ther … read morePosted At: National MS Society
- Next story Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
- Previous story Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Join Our Mailing List
- Interim Results Presented from HSCT Bone Marrow Stem Cell Transplantation Trial
- Study Suggests Treating Psychiatric Problems in MS May Reduce Later Progressive Disability
- Multiple sclerosis: Have researchers found a key to prevention?
- Results Announced from Clinical Trial of Idebenone in Primary Progressive MS
- Surprise finding could lead to new MS treatmentsPosted At: Science Daily
- Ten New Novel Research Projects Focus on MS Fatigue, Gut Bugs, Transcranial Stimulation and More
- Could a sunny climate prevent MS?
- Zinbryta (daclizumab), a Therapy for Relapsing MS, is Withdrawn from Market
- Could eating more fish lower MS risk?
- Does Eating Fish Protect Against MS? One of Many Studies to be Featured at Upcoming AAN Meeting